Cancer Management and Research
| 短名 | CMAR |
| Journal Impact | 2.65 |
| 国际分区 | ONCOLOGY(Q3) |
| 期刊索引 | SCI Q3中科院 4 区 |
| ISSN | 1179-1322 |
| h-index | 67 |
| 国内分区 | 医学(4区)医学肿瘤学(4区) |
《癌症管理与研究》是一本国际同行评审的开放获取期刊，专注于癌症研究以及预防性和综合治疗干预措施的最佳使用，以改善癌症患者的预后、提高生存率和生活质量。该期刊涵盖的具体主题包括：◦流行病学、检测和筛查◦细胞研究和生物标志物◦识别具有新作用机制的生物靶点和药物◦现有抗癌药物的最佳临床应用，包括联合疗法◦放射和手术◦姑息治疗◦患者依从性、生活质量、满意度该杂志欢迎提交的论文涵盖原始研究、基础科学、临床和流行病学研究、评论和评估、指南、专家意见和评论，以及对疾病或疾病亚型提供新见解的案例系列。
期刊主页投稿网址| 涉及主题 | 医学生物遗传学内科学癌症病理化学生物化学肿瘤科外科癌症研究基因数学免疫学统计细胞凋亡放射科 |
| 出版信息 | 出版商: Dove Medical Press Ltd，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2010，原创研究文献占比: 77.30%，自引率:0.00%， Gold OA占比: 96.28% |
| 平均审稿周期 | 网友分享经验：16 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery
2024-9-1
Tiaogan Bushen Xiaoji Formula Enhances the Sensitivity of Estrogen Receptor- Positive Breast Cancer to Tamoxifen by Inhibiting the TGF-β/SMAD Pathway
2024-9-1
Impact of Chemotherapy on Circulating Lymphocyte Subsets in Lung Cancer Patients
2024-9-1
Green Dentistry in Oral Cancer Treatment Using Biosynthesis Superparamagnetic Iron Oxide Nanoparticles: A Systematic Review
2024-9-1
Key Cell-in-Cell Related Genes are Identified by Bioinformatics and Experiments in Glioblastoma
2024-9-1
Ultrasound Diagnosis of Bilateral Primary Breast Burkitt Lymphoma in a 28-Year-Old Lactating Patient: A Case Report
2024-9-1
Machine Learning-Based Predictive Model for Mortality in Female Breast Cancer Patients Considering Lifestyle Factors
2024-9-1
Systematic Review of the Cost-Effectiveness of Home-Based Palliative Care Interventions in Patients with Cancer: A Critical Analysis
2024-9-1
Factors Predicting Treatment Adherence in Outpatients with Cancer-Related Edema: Decision Tree Analysis
2024-9-1
Safety and Efficacy of Neoadjuvant Chemoimmunotherapy versus Chemotherapy for Non-Small Cell Lung Cancer Undergoing Sleeve Resection
2024-9-1
Impact of COVID-19 Pandemic on the Clinical and Pathologic Characteristics of Colorectal Cancer: A Retrospective Multicenter Study in South Korea
2024-9-1
Machine Learning Prediction of Residual and Recurrent High-Grade CIN Post-LEEP
2024-9-1
Long Non-Coding RNA JPX Contributes to Tumorigenesis by Regulating miR-5195-3p/VEGFA in Non-Small Cell Lung Cancer [Retraction]
2024-8-1
The Effect of Hounsfield Unit Value on the Differentiation of Malignant/Benign Mediastinal Lymphadenopathy and Masses Diagnosed by Endobronchial Ultrasonography
2024-8-1
Outcomes After Multimodality Treatment of Pancreatic Cancer in an Unselected Single-Center Cohort
2024-8-1
Radiation-Induced Cognitive Decline: Challenges and Solutions
2024-8-1
Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell Carcinoma
2024-8-1
Circular RNA Profiling Reveals That circRNA_104433 Regulates Cell Growth by Targeting miR-497-5p in Gastric Cancer [Retraction]
2024-8-1
The Opposite Role of Alternatively Spliced Isoforms of LINC00477 in Gastric Cancer [Retraction]
2024-8-1
Influence of Financial Toxicity on the Quality of Life in Lung Cancer Patients Undergoing Immunotherapy: The Mediating Effect of Self-Perceived Burden
2024-8-1
Prognostic Nutritional Index (PNI): A More Promising Nutritional Predictor for Patients Undergoing Surgery for Retroperitoneal Liposarcoma
2024-8-1
Functional Variants of lncRNA LINC00673 and Gastric Cancer Susceptibility: a Case-Control Study in a Chinese Population [Retraction]
2024-8-1
Urine Phthalate Metabolites are Elevated in Patients with Esophageal Squamous Cell Carcinoma and Associated with Advanced Cancer Stage and Poor Survival
2024-8-1
Latest Research Progress of Liquid Biopsy in Tumor—A Narrative Review
2024-8-1
The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study
2024-8-1
The Construction of a Nomogram Using the Pan-Immune-Inflammation Value Combined with a PILE Score for Immunotherapy Prediction Prognosis in Advanced NSCLC
2024-7-1
Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents
2024-7-1
An Assessment of Cryopreserved Semen and Testicular Tissue Collected Before and After Cancer Treatment Initiation
2024-7-1
Low Levels of Natural Killer Cell in Newly Diagnosed Myelodysplastic Syndromes Patients May Confer Poor Prognosis: A Retrospective Cohort Study
2024-7-1
Importance of Testing for ROS1 Rearrangements in Non-Small Cell Lung Cancer in the Era of Targeted Therapy in a Latin American Country
2024-7-1
Multimodal Machine Learning-Based Ductal Carcinoma in situ Prediction from Breast Fibromatosis
2024-7-1
Predictive Value of PERCIST for Locally Advanced Non-Small Cell Lung Cancer Treated with Preoperative Induction Therapy – A Multicenter Study in Japan
2024-7-1
Astragalus membranaceus: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer
2024-7-1
Reference Ranges and Comparison of Pepsinogen by Chemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in Chinese Population
2024-7-1
Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation–Positive Melanoma: Patient Selection and Perspectives
2024-7-1
The Effect of Intracranial Control After Intracranial Local Therapy on the Prognosis of Patients with Brain Metastasis of Lung Adenocarcinoma
2024-7-1
Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma Treated in US Oncology Practices
2024-7-1
Investigation of the Effectiveness of Prostate Biopsy Density in Predicting Prostate Cancer Under Cognitive and Systematic Biopsy in Multi-Parametric Magnetic Resonance Imaging (mpMRI)
2024-7-1
Silencing Exosomal circ102927 Inhibits Foot Melanoma Metastasis via Regulating Invasiveness, Epithelial-Mesenchymal Transition and Apoptosis
2024-7-1
Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer
2024-7-1
Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence
2024-7-1
Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors
2024-7-1
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making
2024-7-1
Retinol Binding Protein 4 Serves as a Potential Tumor Biomarker and Promotes Malignant Behavior in Gastric Cancer
2024-7-1
Successful Treatment of Severe Steroid-Resistant Engraftment Syndrome Following Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia with Emapalumab: A Case Report
2024-6-1
Sign of Neck Mass as the Chief Complaint: A Case Report and Literature Review About Thyroid Metastasis of Colorectal Cancer
2024-6-1
Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching Analysis
2024-6-1
Efficacy and Safety of Chidamide in Combination with PD-1 Inhibitor and Radiotherapy for HER2-Negative Advanced Breast Cancer: Study Protocol of a Single Arm Prospective Study
2024-6-1
Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer
2024-6-1
JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination [Retraction]
2024-6-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远